The test, which is in late-stage development, is expected to hit the market in 2026 with an estimated price tag of $250. That’s per cancer type, with bundled discounts for multi-cancer screenings.

Among the eight participants whose cancers the MCED test detected months before diagnosis, five died from the disease — underscoring how deadly cancer can be when caught too late. For example ...

A routine blood test may be able to detect cancer more than three years before diagnosis, a new study suggests. In the study, published May 22 in Cancer Discovery, researchers at Johns Hopkins ...

Researchers at Johns Hopkins University have discovered that specific blood tests can be used for the early detection of cancer. These tests can identify and diagnose cancer up to three years ...

Johns Hopkins researchers found that tumor-derived mutations can be detected in blood up to three years before cancer diagnosis, offering the potential for earlier intervention.

The test kit from Craif Inc., a spin-off from Nagoya University founded in 2018, can also be used to assess simultaneously whether a person is at risk from any of up to seven types of cancer.

These are men, he said, who are screened year after year with the PSA, a blood test that can pick up signs of prostate cancer. Year after year, their PSA is very low. Then, suddenly, it soars.